Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ANDRX CORP (ADRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/05/2007 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/31/2006 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/23/2006 SC 13D/A ANDRX CORP reports a 9.2% stake in Andrx Corporation
10/05/2006 SC 13D/A ANDRX CORP reports a 11.1% stake in Andrx Corporation
09/13/2006 8-K Quarterly results
08/09/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2006 SECOND QUARTER"
08/08/2006 10-Q Quarterly Report for the period ended June 30, 2006
07/10/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Letter agreement dated July 7, 2006, by and among Watson Pharmaceuticals, Inc., a Nevada corporation, Water Delaware, Inc., and Andrx Corporation, a Delaware corporation",
"WATSON AND ANDRX AMEND MERGER AGREEMENT - Deadline Extended to November 13, 2006 to Allow for Further FTC Review -"
06/12/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/02/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/26/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/17/2006 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
05/05/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/05/2006 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2006 FIRST QUARTER"
05/04/2006 10-Q Quarterly Report for the period ended March 31, 2006
05/03/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/03/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "WATSON PHARMACEUTICALS and ANDRX CORPORATION RECEIVE FTC SECOND REQUEST"
05/01/2006 10-K/A Annual Report for the period ended December 31, 2005 [amend]
04/25/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "4"
04/19/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/19/2006 8-K Other Events
04/04/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/03/2006 10-Q/A Quarterly Report for the period ended June 30, 2005 [amend]
03/30/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/17/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/17/2006 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2005 FOURTH QUARTER AND FULL YEAR"
03/16/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/16/2006 10-K Annual Report for the period ended December 31, 2005
03/16/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "0",
"0",
"0",
"0"
03/14/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/13/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/13/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/13/2006 8-K Other Events
03/13/2006 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Agreement and Plan of Merger by and among Watson Pharmaceuticals, Inc., Water Delaware, Inc. and Andrx Corporation",
"Amendment to Rights Agreement between Andrx Corporation and American Stock Transfer & Trust Company",
"Andrx to be acquired by Watson for $25.00 Per Share"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy